`

Aramis Biotechnologies

Biotechnology Research

Specialities :
Biotechnology
Vaccines
Pandemic prepardness
Plant-based
Biomanufacturing

+2

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
51 - 200

Frequently Asked Questions About Aramis Biotechnologies

What does Aramis biotechnologies do?+

Aramis Biotechnologies is a Canadian company founded in 2023 and based in Quebec City, specializing in the production of innovative vaccines in plants. Benefiting from a unique technology derived from 20 years of research and development, we are committed to shaping a future in which biotechnology sustainably meets global human health needs. By joining forces with our team of shareholder-employees, we are committed to developing innovative vaccines and fostering a culture of solidarity and responsibility. Following an initial startup phase, we will soon welcome new team members to successfully carry out our mission! Follow our page to discover future job...

What are Aramis biotechnologies's specialties? +

Biotechnology,vaccines,pandemic prepardness,plant-based,biomanufacturing,préparation pandémique,and biofabrication

What is Aramis biotechnologies's industry? +

Aramis biotechnologies operates in the Biotechnology research industry.

What is Aramis biotechnologies's revenue? +

Aramis biotechnologies's revenue is 11m - 100m

What is Aramis biotechnologies's company size? +

Aramis biotechnologies has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.